Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 2,320.00
0.00 (0.00%)
At close: Nov 13, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 53.65 billion as of November 13, 2026. It is the 31,518th most valuable company in the world and the 1,711th biggest in South Korea. Its market cap has decreased by 20.62% in one year.
Market Cap
53.65B
Enterprise Value
45.85B
Revenue
27.38B
Global Rank
Country Rank
#1,711 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 22, 2018, Cytogen's market cap has decreased from 87.89B to 53.65B, a decrease of -38.95%. That is a compound annual growth rate of -6.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 53.65B | -74.13% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 211.30B |
| Dx & Vx | 204.24B |
| GC Medical Science | 69.37B |
| Inventera | 60.57B |
| GENINUS | 53.53B |
| Protia | 53.23B |
| HLB Panagene | 48.17B |
| Seoulin Bioscience | 29.06B |